Cowen and Company released an extensive report on the cannabis industry today, suggesting the recreational market could grow to $50 billion by 2026. While this isn’t the first time...
UBC and Tilray Launch Canada’s First Clinical Trial to Study Medical Cannabis and PTSD Research to examine medical risks and benefits for veterans, first responders and sexual assault survivors...
Tilray, the Nanaimo-based licensed producer under Canada’s MMPR program, hired a Canadian Big Pharma executive, Greg Engel, in early 2015 as its first CEO. At the time, he explained why...
Tilray Becomes First Company to Legally Export Medical Cannabis Products from North America to the European Union Global medical cannabis leader proud to help Croatian patients in need GROZNJAN,...
As if the challenges of running a cannabis cultivation business aren’t great enough, some in the industry expect that domestic growers could soon see international competition. While cannabis remains...
Health Canada, which oversees the Canadian medical cannabis program, MMPR, reported data for the quarter ending 12/31/15 today. The number of patients enrolled in the program grew 29.9% from...
Tilray, New South Wales Government, University of Sydney and the Chris O’Brien Lifehouse Announce Clinical Trial Partnership for Cannabinoid Use to Combat Nausea and Vomiting Resulting from Chemotherapy Treatment...
After waiting more than six months, cannabis producers Tilray, which is owned by Privateer Holdings, Tweed, a subsidiary of Canopy Growth (TSXV: CGC), and Whistler Medical, partially owned by...
Following a powerful keynote speech by Drug Policy Alliance Executive Director Ethan Nadelmann, attendees at the Cannabis Private Investment Summit, organized by Noa Kahner of Kahner Global, were treated...
One of the continuing challenges that new PM Justin Trudeau and his administration will need to address is the continued flagrant violation of federal laws that prohibit cannabis dispensaries....
Brendan Kennedy, CEO of Seattle-based private equity firm Privateer Holdings, one of the fifteen “marijuana money managers” profiled at New Cannabis Ventures and a pioneer investor in the cannabis industry, spoke at...
Greg Engel, the former pharmaceutical executive who was named as CEO of Canadian licensed cannabis producer Tilray earlier this year, wrote an editorial that was published by the National...
One of Canada’s largest newspapers, The Globe and Mail, took a look at the rapidly evolving approaches to marketing cannabis and its ancillary products in an increasingly legal environment. While...
The federal Liberals’ campaign promise to legalize recreational pot will likely shake up the economics of both the black market and medical cannabis industries, say experts. But B.C. marijuana...
One of the highlights of the National Cannabis Summit in Denver was the 90-minute panel entitled “Investing in the Canadian Cannabis Sector”. The participants included the CEO of merchant...
NANAIMO, BRITISH COLUMBIA, Oct 05, 2015 Tilray, one of Canada’s largest and most reputable licensed producers of medical cannabis, today unveiled a broad-based line of 20 different medical cannabis...
Meet Brendan Kennedy, ceo of the private equity firm Privateer Holdings. He arrives at our meeting carrying a bowl of nuts. He’s been up with his nine-month-old daughter since...
Medical marijuana producers are bracing for the possibility that Canadians could elect a new government this fall — a change that could accelerate the already breakneck pace of growth...
